¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"multiple drug resistant tuberculosis"¿¡ ´ëÇÑ KI ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
drug
¾à, ¾à¹°, ¾àÁ¦
drug abuse
¾à¹°³²¿ë
narcotic drug
¸¶¾à
tuberculostatic drug
Ç×°áÇÙ¾à
hematogenous tuberculosis
Ç÷Ç༺°áÇÙ
miliary tuberculosis
¼Ó¸³¼º°áÇÙ(Áõ)
primary tuberculosis
ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
pulmonary tuberculosis
Æó°áÇÙ
secondary tuberculosis
ÀÌÂ÷¼º°áÇÙ
tuberculosis
°áÇÙ(Áõ)
MOTSA [=multiple overlapping thin-slab acquisition]
´ÙÁßÁߺ¹¼¼ÆíÆÇȹµæ
multiple
´Ù¹ß¼º
multiple cranial nerve palsy
´Ù¹ß¼º³ú½Å°æ¸¶ºñ
multiple echo
´ÙÁß¿¡ÄÚ
multiple epiphyseal dysplasia
´Ù¹ß¼º°ñ´ÜÀÌÇü¼ºÁõ
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½